Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 11 Dec 2025 for Replimune Group, Inc., €28k.
Filing timeline
BuySaleKapil Dhingra
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Kapil Dhingra: trading record in brief
Kapil Dhingra discloses dealings in 2 companies, chiefly Replimune Group, Inc. and LAVA Therapeutics NV. In total, 7 filings cover trades dated from 7 December 2020 to 9 December 2025.
Sales make up the whole of the open-market record (4 sales, €1.5M). Outside the open market, there are 2 option exercises. So far in 2025, the count stands at no purchases and 1 sale.
On 11 December 2025 came the latest disclosure, an open-market sale for €28k in Replimune Group, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kapil Dhingra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,169 shares@ US$10.401.8% of flowCommon StockSEC:0001104659-25-120332:1
3,169 shares@ US$1.75100.0% of flowCommon StockSEC:0001104659-25-120332:0
30,000 sharesCommon SharesSEC:0001456849-25-000005:0
40,000 shares@ US$1.753.7% of flowCommon StockSEC:0001104659-20-133812:0
24,675 shares@ US$45.0958.6% of flowCommon StockSEC:0001104659-20-133812:1
13,523 shares@ US$46.2232.9% of flowCommon StockSEC:0001104659-20-133812:2
1,802 shares@ US$47.044.5% of flowCommon StockSEC:0001104659-20-133812:3
7 of 7 declarations
